| 11/20/2024 | BKDD | S&P cuts Aegis Toxicology
|
| 6/24/2024 | BKDD | Moody's downgrades Aegis Toxicology
|
| 6/21/2024 | BKDD | S&P trims Aegis Toxicology Sciences
|
| 6/21/2023 | BK | Moody's snips Aegis Toxicology
|
| 11/5/2021 | BK | S&P lifts Aegis Toxicology
|
| 10/1/2021 | BK | Moody's ups Aegis Toxicology
|
| 1/19/2021 | BKDDHY | Moody's elevates Aegis Toxicology
|
| 12/18/2020 | BK | S&P shifts Aegis view to positive
|
| 3/23/2020 | BK | Fitch lowers Alpha Group
|
| 3/23/2020 | BK | S&P revises Aegis Toxicology view to negative
|
| 1/22/2020 | BKDD | Moody’s cuts Aegis Toxicology Sciences
|
| 7/11/2019 | BK | S&P cuts Aegis Toxicology
|
| 1/11/2019 | BK | Moody’s changes Aegis view to stable
|
| 7/6/2018 | BK | S&P changes Aegis to stable
|
| 5/4/2018 | BK | Market Commentary: Laird, EnergySolutions, WireCo, Aegis Toxicology, KeyW, Odyssey Logistics, Arterra break
|
| 5/4/2018 | BK | Aegis trims term loan B to $300 million, flexes to Libor plus 550 bps
|
| 4/13/2018 | BK | Market Commentary: Caesars, H.B. Fuller, EIF Channelview, LA Fitness, LegalShield, Seminole, Golden Nugget break
|
| 4/13/2018 | BK | S&P assigns B to Aegis Toxicology revolver
|
| 4/13/2018 | BK | Moody’s rates Aegis loans B3
|
| 4/13/2018 | BK | Aegis Toxicology talks $320 million term B at Libor plus 500-525 bps
|
| 1/9/2017 | BK | Moody’s cuts Aegis Toxicology, loan
|
